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Abstract
Inflammatory immune responses induced by lipopolysaccharides (LPS) of gram-negative
bacteria play an important role in the pathogenesis of preterm labor and delivery, and in neo-
natal disorders. To better characterize LPS-induced inflammatory response, we determined
the cytokine profile of umbilical cord blood mononuclear cells (UBMC) stimulated with LPS
of seven vaginal gram-negative bacteria commonly found in pregnant women with preterm
labor and preterm rupture of membrane. UBMC from ten newborns of healthy volunteer
mothers were stimulated with purified LPS of Escherichia coli, Enterobacter aerogenes,
Klebsiella pneumoniae, Proteus mirabilis, Acinetobacter calcoaceticus, Citrobacter freundii,
and Pseudomonas aeruginosa. UBMC supernatants were tested for the presence of
secreted pro-inflammatory cytokines (IL-6, IL-1β, TNF), anti-inflammatory cytokine (IL-10),
TH1-type cytokines (IL-12, IFN-γ), and chemokines (IL-8, MIP-1α, MIP-1β, MCP-1) by Lumi-
nex technology. The ten cytokines were differentially induced by the LPS variants. LPS of E.
coli and E. aerogenes showed the strongest stimulatory activity and P. aeruginosa the low-
est. Interestingly, the ability of UBMC to respond to LPS varied greatly among donors, sug-
gesting a strong individual heterogeneity in LPS-triggered inflammatory response.
Introduction
Preterm birth is the most common cause of neonatal death [1]. It is associated with increased
neonatal short- and long-term morbidity including severe damages to the brain, bowel, lungs,
eyes and developmental defects [2–5]. Preterm labor (PTL) is defined as labor arising from
premature uterine contractility and occurs prior to 37 weeks of gestation in human. In the
United States, approximately 10% of all births are diagnosed as preterm [6] and 15 million pre-
mature babies are estimated to be born annually worldwide as a result of PTL [7].
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As many as 40% of spontaneous preterm births may be attributed to antenatal infection [8]
and nearly half of the three million neonatal deaths that occur annually are due to bacterial
infections [9]. Ascending genital tract infections of the vagina represent a major cause of PTL,
spontaneous preterm birth and preterm rupture of membrane (PROM). Intra-amniotic infec-
tion has been causally linked to spontaneous PTL [10]. Indeed, preterm deliveries ensue fre-
quently from an increase in bacterial colonization, which originates as bacterial vaginosis and
spreads over gestational tissues including choriodecidua, fetal membranes, amniotic cavity,
and eventually the fetus. Bacterial vaginosis up to the 26th week of gestation increases a
woman´s risk of preterm delivery by 50% [11], and intrauterine infection is often associated
with chorioamnionitis [12,13]. Neonates born to mothers with clinical chorioamnionitis are at
risk for sepsis [14–16], meconium aspiration syndrome [17], neonatal encephalopathy [18],
long-term neurodevelopmental disabilities including cognitive impairment [19,20] and cere-
bral palsy [21].
PTL exhibit a common feature whereby an increase in inflammatory mediators, such as
TNF, IL-1, IL-6 and IL-8, is observed in the amniotic fluid before the onset of uterine contrac-
tion. Thus, it is currently assumed that PTL is triggered by premature emergence of these pro-
inflammatory mediators in gestational tissues [22]. These pro-inflammatory cytokines might
also be the link between prenatal intrauterine infection and intraventricular hemorrhage,
resulting in neonatal white matter damage and subsequent cerebral palsy in preterm delivered
newborns [23,24]. Maternal systemic inflammation during critical windows of pregnancy may
even predispose the neonate to autism spectrum disorders [25] and schizophrenia [26].
Gram-negative bacteria are known to cause severe neonatal infections and associated com-
plications, such as meningitis, cerebral abscesses, septicaemias and sudden unexpected death
in neonates and infants [27–32]. Gram-negative bacteria express a glycolipid component called
endotoxin or lipopolysaccharide (LPS) which participates in the physiological functions of the
outer bacterial membrane and is the principal inflammatory component of the gram-negative
bacterial envelope [33,34]. LPS signals through Toll-like receptor 4 (TLR4), a member of the
TLR family belonging to the pattern recognition receptor family. LPS stimulation via TLR4
results in inflammatory cytokine production, which is responsible for activating the innate
immune system [35]. Various cytokines are produced in PTL caused by bacterial infections,
via the LPS/TLR4 pathway, causing maternal but also fetal pathologies, such as brain damage,
pulmonary or intestinal complications [36–38]. LPS-mediated inflammatory response is
clearly correlated to prematurity or fetal loss [39–42]. A role of the CX3CL1-CX3CR1 chemo-
kine signaling pathway through intrauterine recruitment of macrophages and the enhance-
ment of macrophage-derived inflammatory mediators was recently demonstrated in LPS-
induced PTL in mice [43].
LPS are large molecules consisting of a lipid (Lipid A) covalently bound to a polysaccharide
[33,34]. Because of the limited variability in their structure, it was initially assumed that all LPS
molecules have comparable biological activities. However, it has now been shown that LPS
from different bacterial species are structurally and functionally distinct. In vitro experiments
have demonstrated great variance in the capacity of different LPS species to induce the synthe-
sis of cytokines [44]. The shape of the Lipid A determines the bioactivity of the LPS [45]. Lipid
A that adopts a conical shape conformation (e.g. E. coli) is more active than one that adopts a
cylindrical conformation [46]. Gram-negative bacteria have developed numerous mechanisms
for the modification of lipid A. These mechanisms include the expression of enzymes adding
or removing acyl chains phosphate groups, or altering the acylation state of their LPS in
response to environmental changes, or catalyzing the addition of chemical groups into the
phosphates [47]. These modifications affect the recognition of LPS by TLR4 and thus impact
the downstream inflammatory and immune responses [48]. Differences in TLR4 function and
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regulation in adult and neonatal monocytes have also been described [49–51]. These may
account for the attenuated cytokine responses in neonates and the immaturity of infection
control noted in preterm and term newborns in association with impaired TLR signaling [52].
We previously examined the distribution of gram-negative bacteria in vaginal and cervical
swabs of 239 pregnant women with PROM or PTL at our clinic and identified seven species at
the following frequency: E. coli (90%), Klebsiella spp. (12%), Proteus spp. (9%), Pseudomonas
spp. (5%), Morganella morganii (2%), Enterobacter spp. (2%), Citrobacter spp. (2%) and Aci-
netobacter (2%) [53].
We hypothesized that LPS of different gram-negative bacteria present in the vagina of preg-
nant women induce the release of different cytokine and chemokine profiles, possibly resulting
in distinct immunomodulatory activities. We verified this hypothesis by using an in vitro sys-
tem of freshly isolated umbilical cord blood mononuclear cells (UBMC) stimulated with puri-
fied LPS of clinically relevant gram-negative vaginal bacteria. UBMC isolated from ten
uncomplicated at-term deliveries were stimulated with purified LPS and the release of a broad
panel of immunomodulatory cytokines and chemokines was measured using the Luminex
technology.
Materials and methods
Umbilical cord blood source
Informed consent was obtained from ten voluntary healthy mothers. Participants were non-
smokers, were not under medical treatment, showed no signs of infection during pregnancy
and delivered at term. Umbilical cord blood was collected immediately at birth in citrate bags,
following ligation of the umbilical cord, and processed within 12 hours. The protocol of the
study was conducted in accordance with the World Medical Association Declaration of Hel-
sinki and approved by the Ethical Commission of the University of Regensburg, Center for
Clinical Studies (Approval number 06/098).
Isolation of umbilical cord blood mononuclear cells (UBMC)
The freshly citrated umbilical cord blood was diluted 1:3 with PBS, and 25 to 30 ml diluted
blood was carefully laid over 15 ml Pancoll (Lymphocyte sep. medium/ Pancoll human, den-
sity 1.077 g/ml, PAN, Biotech, Aidenbach, Germany). UBMC were separated by density gradi-
ent centrifugation (800 x g, 30 min) at room temperature (RT), harvested as a single interface
layer, and washed three times with 45 ml PBS. Contaminating erythroblasts were eliminated
by lysis in 1 ml erythrocyte lysis buffer (BD Pharm LyseTM LYSING BUFFER, Cat. No.
555899) for 10 min at RT, followed by two additional washes in 45 ml PBS. Cell pellets of each
donor were resuspended in T-cell medium (RPMI 1640 medium, Gibco, Paisley, Scotland)
supplemented with 10% heat-inactivated human AB serum, and enumerated using a Neubauer
counting chamber. Total cell number was adjusted to 2 x 105 cells per 90 μl in T-cell medium.
Purified LPS
Purified LPS of selected gram-negative bacteria species were kindly provided by the reference
center Research Center Borstel, Leibniz Lung Center (Germany). LPS of the following gram-
negative bacteria species were extracted from isolates of various origins as described: E. coli
GH58 [54], E. aerogenes 1033 [55], P. mirabilis rough mutant R45 [56], K. pneumoniae rough
mutant R20/01 [57], A. calcoaceticus NCTC 10305 [58], C. freundii (S-Form LPS purified by
gel permeation chromatography) [59], and P. aeruginosa PAO1 [60].
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Stimulation of UBMC with LPS
Freshly isolated UBMC (2 x 105) were seeded in triplicate (90 μl per well) into polypropylene
plastic 96-well plates (Nunc, Roskilde, Denmark). Unless otherwise indicated, cells were stim-
ulated with 37.5 ng/ml purified LPS in 100 μl final volume for 36 hours at 37˚C in a humidified
atmosphere containing 5% CO2. UBMC stimulated with PBS served as a negative control. The
synthetic bacterial lipopeptide and TLR1/2 agonist PAM3CSK4 [61] (L2000, EMC Microcol-
lections, Tuebingen) was tested in parallel at the concentration of 37.5 ng/ml. Cell-free super-
natants of stimulated cells were harvested by low speed centrifugation (300 x g, 10 min) and
stored at -80˚C.
Determination of cytokine and chemokine concentrations in UBMC
supernatants
The levels of cytokines and chemokines in the UBMC supernatants were determined applying
the Luminex technology (MicroBIOMix GmbH, Regensburg). A pilot experiment on one sub-
ject was performed using the Human Cytokine 30-Plex panel (LHC6003, Invitrogen/Thermo-
Fisher), which includes the following cytokines, chemokines and growth factors: IL-1β, IL-
1-Receptor Antagonist (IL-1RA), IL-2, IL-2 receptor (IL-2R), IL-4, IL-5, IL-6, IL-7, IL-8, IL-
10, IL-12 (protein 40/protein 70), IL-13, IL-15, IL-17, TNF, interferons IFN-α and IFN-γ,
granulocyte-macrophage colony stimulating factor (GM-CSF), macrophage inflammatory
proteins MIP-1α and MIP-1β, interferon-γ-induced protein 10 (IP-10), monokine induced by
interferon-γ (MIG), eotaxin, regulated and normal T-cell expressed and secreted (RANTES),
monocyte chemoattractant protein 1 (MCP-1), vascular endothelial growth factor (VEGF),
granulocyte colony stimulating factor (G-CSF), epidermal growth factor (EGF), fibroblast
growth factor (FGF) and human growth factor (HGF). Further Luminex assays were con-
ducted using the following human singleplex beads kits (Invitrogen/ThermoFisher): IL-1β
(LHC0011), IL-10 (LHC0101), IL-6 (LHC0061), IL-8 (LHC0081), IL-12 [p40/p70] (LHC0121),
TNF (LHC3011), IFN-γ (LHC4031), MIP-1α (LHC1021), MIP-1β (LHC1051), and MCP-1
(LHC1011). Experiments were performed using the Human Extracellular Protein Buffer
Reagent Kit (LHB0001, Invitrogen/ThermoFisher) according to the manufacturers’ protocol.
Table 1. Characteristics of the 10 mothers and respective neonates, as well as storage time of umbilical cord blood from collection at delivery until isolation of
UBMCa.
Subject
number
Maternal age
(years)
Parity Gestational age (weeks
+ days)
Mother´s BMIa before
pregnancy
Baby’s weight at
birth (g)
Baby’s
sex
Time to UCBa processing
(hours)
1 22 1 40 + 3 22.9 3865 Male 11
2 35 1 38 + 6 24.3 3060 Male 3
3 25 2 37 + 0 18.6 3045 Female 12
4 33 2 40 + 1 21.6 3920 Female 9
5 37 3 40 + 4 19.8 3610 Female 9
6 30 2 41 + 2 20.9 3740 Female 5
7 33 2 40 + 0 23.5 3220 Female 3.5
8 27 4 42 + 1 17.5 3850 Male 2.5
9 33 1 40 + 2 26.8 3360 Female 10
10 24 1 39 + 1 25.8 3125 Male 5
Median 31.5 2 40 + 1.5 22.25 3485 7.0
Range 22–37 1–4 37–42 + 0–6 17.5–26.8 3045–3920 2.5–12.0
aAbbreviations: BMI, body mass index; UCB, umbilical cord blood; UBMC, umbilical cord blood mononuclear cells.
https://doi.org/10.1371/journal.pone.0222465.t001
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The assays were performed in 96-well filter bottom plates. The beads were protected from light
throughout the procedure. The lyophilized standard was reconstituted in 2 ml assay diluents
and 1:3 serial dilutions were undertaken to generate a seven standard concentration set, while
diluent alone served as blank. The filtered plates were pre-washed with 200 μl of wash solu-
tion/well for 30 seconds. Wash solutions were aspirated using a vacuum manifold and the bot-
tom of the plate was blotted on paper towels to remove residual liquid. The concentrated bead
mix was diluted 1:20 in wash solution. The bead solution was vortexed and sonicated immedi-
ately prior to adding 50 μl/well. The plate was washed twice with 200 μl wash solution/well as
above. Incubation buffer (50 μl) and each standard (100 μl) were added in duplicate. Assay dil-
uent (50 μl) was added to each well followed by the addition of the sample (50 μl). The plate
was covered and incubated for 2 h at RT on an orbital plate shaker (600 rpm). Afterwards, the
liquid was removed using a vacuum manifold, and the plate was washed twice. A biotinylated
detection antibody (100 μl) was added and plate was covered and incubated on the shaker for
1 h at RT. The plate was washed twice prior to addition of Streptavidin-RPE (100 μl), then cov-
ered and incubated for 30 min at RT on the shaker. Finally, the plate was washed three times.
Wash solution (110 μl) was added to each well, the plate was covered, placed on the orbital
shaker and incubated for 2–3 min at RT prior to analysis. Mean fluorescence intensity (MFI)
was acquired using the Luminex xMAP 100 system (Luminex Corp.). Software was set to
acquire data using 70 μl sample and count 100 events per single bead set.
Statistical analyses
Cyto- and chemokine-concentrations were calculated using a 4- or 5-parameter logistic fit
curve generated from the 7 standards using the Liquichip Analyzer software (Qiagen, Ger-
many) and expressed in ng/ml in accordance with International Standards. Statistical differ-
ences between measured values in stimulated and unstimulated conditions were analyzed
using a Mann-Whitney U-test. P values less than 0.05 were considered statistically significant.
Statistical tests were performed using SPSS 15 (for Windows).
Results
Purified LPS from seven gram-negative vaginally occurring bacteria commonly found in preg-
nant women with PTL and PROM, namely E. coli GH58, E. aerogenes 1033, P. mirabilis rough
mutant R4, K. pneumoniae rough mutant R20/01, A. calcoaceticus NCTC 10305, C. freundii
(S-Form), and P. aeruginosa PAO1 [53], were used to stimulate UBMC freshly isolated at birth
from ten healthy at-term neonates. Secreted cytokines were quantified in the cell culture super-
natant of stimulated UBMC using the Luminex technology. The characteristics of the mothers
and respective newborns are shown in Table 1. Median (range) time from blood collection to
processing was 7.0 (2.5–12.0) hours.
Pilot experiments were performed on Subjects number 1 to 3 to identify an optimal LPS
concentration, duration of stimulation and relevant cytokines (Figs 1–5; Table 2). UBMC of
three donors were stimulated for 36 hours with increasing amounts (from 0.006 to 3027 ng/
ml) of purified LPS (Figs 1–4). A subanalysis was performed on one donor to compare a
4-hour to a 36-hour LPS stimulation on selected cytokines (Fig 5). Based on these experiments,
Fig 1. Dose response of LPS on the release of pro-inflammatory cytokines by UBMC. UBMC isolated from three of the ten deliveries (Subjects 1–3;
Table 1) were stimulated for 36 hours with increasing amounts (0–3027 ng/ml) of purified LPS derived from the indicated seven gram-negative bacteria (E.
coli, E. aerogenes, K. pneumoniae, P. mirabilis, A. calcoaceticus, C. freundii, P. aeruginosa). The levels of pro-inflammatory cytokines (IL-6, IL-1β, TNF)
released in the supernatants of UBMC were measured by Luminex, as described in the Methods section. UBMC of Subject 1 released levels of IL-6 above the
detection range of the Luminex assay (saturated signal), as indicated by the green dotted line and the (�) sign.
https://doi.org/10.1371/journal.pone.0222465.g001
Cytokine profiles of LPS-stimulated umbilical cord blood mononuclear cells (UBMC)
PLOS ONE | https://doi.org/10.1371/journal.pone.0222465 September 19, 2019 6 / 23
Cytokine profiles of LPS-stimulated umbilical cord blood mononuclear cells (UBMC)
PLOS ONE | https://doi.org/10.1371/journal.pone.0222465 September 19, 2019 7 / 23
as well as on reports from the literature [62–65], we selected a LPS concentration of 37.5 ng/ml
and a stimulation duration of 36 hours as optimal to detect significant levels of ten selected
cytokines and chemokines (IL-1β, IL-10, IL-6, IL-8, IL-12 [p40/p70], TNF, IFN-γ, MIP-1α,
MIP-1β, MCP-1). Although the concentration of 37.5 ng/ml LPS was not sufficient to induce a
strong cytokine response in some cases (e.g. P. aeruginosa; Figs 1–4), this working concentra-
tion was chosen to remain in a range of LPS close to that normally detected in the plasma of
patients with sepsis [66]. Additional secreted cytokines and growth factors measured in the
supernatant of one donor using a 30-plex cytokine panel are shown in Table 2. In this donor,
low to high levels of secreted factors were detected (low: IL-2, IL-4, IL-5, IL-13, IP-10, eotaxin,
HGF; intermediate: IL-15, MIG, FGF-basic; high: IL-7, IL-1RA, IL-2R, RANTES, G-CSF,
GM-CSF, VEGF), while IL-17, EGF and IFN-α were undetectable (Table 2).
Seven additional UBMC preparations were stimulated with 37.5 ng/ml LPS for 36 hours.
The same concentration of the synthetic TLR1/TLR2 agonist PAM3 [61] was tested in parallel.
Levels of secreted pro-inflammatory cytokines (IL-6, IL-1β, TNF), anti-inflammatory cytokine
(IL-10), TH1-cytokines (IL-12, IFN-γ), and chemokines (IL-8, MIP-1α, MIP-1β, MCP-1) were
measured by Luminex. Results obtained from the ten donors in comparison to the unstimu-
lated control are shown in Fig 6.
Six out of the seven purified LPS (E. coli, E. aerogenes, P. mirabilis, K. pneumoniae, A. cal-
coaceticus, C. freundii) induced significant levels of the ten cytokines and chemokines investi-
gated (Fig 6A–6C). With the exception of IL-6, LPS from P. aeruginosa did not induce
significant production of pro- and anti-inflammatory cytokines (Fig 6A). It induced however
low but significant levels of chemokines by UBMC (Fig 6C). In comparison, the TLR1/2 ago-
nist PAM3 induced no or weak cytokine production (Fig 6A and 6B), and significant chemo-
kine production (Fig 6C).
The donor-to-donor variability in the levels of detected cytokines was high for all tested
cytokines and chemokines (Figs 1–4 and 6). For instance, the level of TNF in the UBMC super-
natant upon stimulation with LPS from E. coli ranged from 38 to 2763 pg/ml (median TNF
concentration of 309 pg/ml) among the ten donors. Moreover, LPS from different bacterial
species induced distinct cytokines profiles in a given UBMC preparation (Figs 1–4 and 6).
Among the ten donors, LPS from E. coli and E. aerogenes induced the highest median level of
cytokines and chemokines, followed by P. mirabilis and K. pneumoniae. LPS from A. calcoace-
ticus and C. freundii induced further lower median cytokine and chemokines levels, and–as
mentioned above–LPS from P. aeruginosa was the least active (Fig 6A–6C).
After 36 hours of LPS stimulation, the most prominent detected cytokines were the pro-
inflammatory cytokine IL-6 and the chemokines IL-8, MIP-1α, MIP-1β and MCP-1 (median
levels >2,900 pg/ml; Fig 6A–6C). TNF, IL-1β, IL-10 and IL-12 were detected at intermediate
levels (median between 33 and 929 pg/ml; Fig 6A and 6B), and IFN-γ was the lowest (median
level�20 pg/ml in response to all LPS variants; Fig 6B).
Discussion
We describe here the profile of cytokines and chemokines released by UBMC following their
in vitro stimulation by LPS of seven common vaginal gram-negative bacteria species. Four
groups of secreted factors were investigated: pro-inflammatory cytokines (IL-6, IL-1β, TNF),
Fig 2. Dose response of LPS on the release of anti-inflammatory and TH1-type cytokines by UBMC. UBMC isolated from three of the ten deliveries
(Subjects 1–3; Table 1) were stimulated for 36 hours with increasing amounts (0–3027 ng/ml) of purified LPS derived from the indicated seven gram-
negative bacteria (E. coli, E. aerogenes, K. pneumoniae, P. mirabilis, A. calcoaceticus, C. freundii, P. aeruginosa). The levels of anti-inflammatory cytokine (IL-
10) and TH1-type cytokines (IL-12, IFN-γ) released in the supernatants of UBMC were measured by Luminex, as described in the Methods section.
https://doi.org/10.1371/journal.pone.0222465.g002
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an anti-inflammatory cytokine (IL-10), TH1-type cytokines (IL-12, IFN-γ) and chemokines
(IL-8, MIP-1α, MIP-1β, MCP-1). Herein, we could confirm our hypothesis that LPS of differ-
ent gram-negative bacterial species induce distinct inflammatory responses and thus might
exert different immunomodulatory functions. We showed that in vitro stimulation of freshly
isolated UBMC with purified LPS of these bacteria induced different levels of secreted pro-
and anti-inflammatory cytokines and chemokines. Interestingly, the range of cytokine and
chemokine concentrations detected in the supernatants of stimulated UBMC varied drastically
between donors, indicating major differences in individual responsiveness to a given LPS
variant.
All ten cytokines and chemokines were induced in UBMC after 36 hours stimulation with
the different LPS, albeit at different levels, as summarized in Fig 7.
The pro-inflammatory cytokine IL-6 and the chemokines IL-8, MIP-1α, MIP-1β and MCP-
1 showed the highest induction, with median levels ranging from 77 to 196,000 pg/ml upon
LPS stimulation. Elevated IL-6 and IL-8 levels after LPS stimulation of umbilical cord blood
was also reported by others [49,51,67]. Our results thus support the observation that intrauter-
ine infection results in the secretion of pro-inflammatory cytokines and chemokines such as
Il-1ß, Il-6, IL-8, TNF and MCP-1, in association with PTL and fetal brain injury [23,36,39,68–
70].
The anti-inflammatory and TH2-polarizing cytokine IL-10 was induced at low levels
(median 0 to 120 pg/ml) by all seven LPS tested. IL-10 is an important regulator and suppres-
sor of the pro-inflammatory cascade [36]. IL-10 is normally produced at the maternal-fetal
interface, and exerts together with progesterone a strong immunomodulatory protection of
the fetal allograft [36].
IL-12 is an essential cytokine for the generation of the TH1-type immune responses. It is
produced by monocytes and dendritic cells (DC) upon stimulation with LPS [71]. In our study
median IL-12 (p40/p70) levels ranged from 126 to 605 pg/ml in the supernatants of LPS-stimu-
lated UBMC, with maximum levels ranging from 1,450 and 4,593 pg/ml between LPS variants.
Others showed that IL-12 is weakly expressed and secreted in LPS-stimulated whole cord
blood [49,72].
As opposed to IL-12, levels of the TH1 cytokine IFN-γ were consistently low in all donors
and upon stimulation with all seven LPS. This is in line with published report in LPS-stimu-
lated PBMC [73]. However, we cannot exclude that a different duration of LPS stimulation
might allow a better detection of secreted IFN-γ levels. For instance, the level of secreted TNF
in Subject 2 was higher after 4 hours of LPS stimulation with all seven LPS variants than after
36 hours.
Other studies compared the response to LPS of UBMC to that of adult peripheral blood
mononuclear cells. Some studies showed a reduced cytokine production (e.g. IL-12) in LPS-
stimulated whole cord blood compared to adult whole blood [49,72], supporting the proposi-
tion that TLR4-mediated response is impaired in neonates and infants [50,52,72]. Other stud-
ies however described an elevated cytokine responses, in particular of IL-6, TNF, IL-8 and IL-
10 [49,51,67], and even a newborn-specific cytokine production [74] after LPS stimulation of
umbilical cord blood. These differences in reported LPS responsiveness might be a
Fig 3. Dose response of LPS on the release of chemokines by UBMC. UBMC isolated from three of the ten deliveries
(Subjects 1–3; Table 1) were stimulated for 36 hours with increasing amounts (0–3027 ng/ml) of purified LPS derived from the
indicated seven gram-negative bacteria (E. coli, E. aerogenes, K. pneumoniae, P. mirabilis, A. calcoaceticus, C. freundii, P.
aeruginosa). The levels of chemokines (IL-8, MCP-1) released in the supernatants of UBMC were measured by Luminex, as
described in the Methods section.
https://doi.org/10.1371/journal.pone.0222465.g003
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consequence of differential TLR4 regulation, due to differences in TLR4 expression in neo-
nates and adults [49,51,75] and/or due to TLR4 gene polymorphism [76].
Alternatively, these functional differences in LPS responsiveness might also be due to the
use of LPS of different origin and species in these reported studies. Indeed, in our study the
comparison of the stimulatory activity of purified LPS from seven common gram-negative
bacteria species revealed functional differences. LPS of E. coli and E. aerogenes provoked the
highest cytokine and chemokine release, while LPS of P. aeruginosa was the least active. The
low stimulatory activity of LPS of P. aeruginosa might be explained by its reduced acylation
state, which is an important component of TLR4 recognition, compared to other LPS [47].
The observed differences in LPS activity therefore confirm our hypothesis that different LPS
molecules potentially mediate different inflammatory responses, in line with reports from the
literature [44,46–48]. Our data are also in agreement with the virulence and neonatal compli-
cations associated with E. coli, including neonatal sepsis [77–79] and with E. aerogenes infec-
tions [80,81].
In addition, we observed striking differences in the responsiveness of the ten UBMC prepa-
rations, resulting in skewed levels of cytokine release. Higher cytokine release in some donors
did not correlate with longer cord blood storage before UBMC isolation (Fig 5 and Table 1).
Therefore higher cytokine release cannot be accounted for artefactual cytokine release by con-
taminating granulocytes, which are known to accumulate in the mononuclear cell layer during
density gradient centrifugation in case of delayed blood processing [82,83]. The reason for
such variability in cytokine levels is unknown and remains to be investigated. It might be the
consequence of differences in TLR4 function between donors, due to differential gene expres-
sion and/or polymorphism [75,76]. Nevertheless, the observation that UBMC of neonates
born after uncomplicated gestation and delivery produce such variable levels of cytokines
upon LPS stimulation raises the possibility that pregnant women might experience different
levels of inflammatory response following a bacterial infection, potentially differentially affect-
ing pregnancy outcome. It would be interesting to compare these results to those generated
from UBMC of premature neonates with a declared bacterial infection.
Prevention of infection remains the most promising approach to reduce PTL and associated
mortality and morbidity in this highly vulnerable neonatal population. Diagnostic and treat-
ment of prenatal and neonatal infections is a major challenge. The present study suggests that
measuring cytokine levels might guide the diagnosis of bacterial infections. Interestingly, oth-
ers showed that it is possible to measure cytokine levels in amniotic fluid collected noninva-
sively from vaginal secretions of women with preterm premature rupture of membranes.
Increased levels of amniotic fluid IL-6 and TNF were good predictors of fetal inflammatory
response syndrome [84]. By using the umbilical cord as a noninvasive source of neonatal
blood, as in our study, one may be able to establish the cytokine profile of neonates and evalu-
ate their risk of infection-related complications after birth.
In terms of treatment of prenatal and neonatal infections, antibiotics acting against gram-
negative bacteria exist. However, antenatal antibiotic treatment alone has limited success at
preventing PTL or improving neonatal outcome [85]. A combination of anti-inflammatory
therapy and effective antibiotics has been proposed to combat intra-uterine infection and
Fig 4. Dose response of LPS on the release of chemokines by UBMC. UBMC isolated from three of the ten deliveries
(Subjects 1–3; Table 1) were stimulated for 36 hours with increasing amounts (0–3027 ng/ml) of purified LPS derived from the
indicated seven gram-negative bacteria (E. coli, E. aerogenes, K. pneumoniae, P. mirabilis, A. calcoaceticus, C. freundii, P.
aeruginosa). The levels of chemokines (MIP-1α, MIP-1β) released in the supernatants of UBMC were measured by Luminex,
as described in the Methods section. Based on the assays presented in Figs 1–4, the concentration of 37.5 ng/ml LPS was used
for further experiments.
https://doi.org/10.1371/journal.pone.0222465.g004
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reduce associated inflammatory responses leading to PTL and adverse fetal sequelae. Optimal
treatments also increase the survival of premature infants by promoting lung maturation, as
illustrated by the combination of betamethasone with tocolytic agents such as nonsteroidal
anti-inflammatory drugs (NSAIDs) like indomethacin. The anti-inflammatory effect of the
combination therapy of betamethasone with indomethacin might also reduce bacterial clear-
ance. Our group showed furthermore that, similar to betamethasone alone, the combination
therapy effectively reduced the expression of the pro-inflammatory cytokines TNF, IL-6 and
IL-12 [86]. Other studies even suggested that a postnatal application of indomethacin to pre-
term neonates delivered before 28 weeks of gestation provided beneficial effects on the fetal
brain [87]. This neuroprotective effects of indomethacin might be due to an increase of cere-
bral vascular resistance and stability of cerebral hemodynamics [88,89]. Additionally to
NSAIDs, cytokine suppressive anti-inflammatory drugs (CSAIDs) are novel compounds that
specifically target cytokine signaling pathways, exerting anti-inflammatory actions in both
Fig 5. Dose response and time course of LPS on the release of cytokines and chemokines by UBMC. UBMC isolated from Subject 2 (Table 1) were
stimulated for either 4 or 36 hours with increasing amounts (0–3027 ng/ml) of purified LPS derived from the indicated seven gram-negative bacteria (E. coli,
E. aerogenes, K. pneumoniae, P. mirabilis, A. calcoaceticus, C. freundii, P. aeruginosa). The levels of IL-12, IL-6 and TNF released in the UBMC supernatant
were measured by Luminex, as described in the Methods section. Based on these preliminary assays (and reports from the literature; see text), a stimulation
duration of 36 h was used for further experiments.
https://doi.org/10.1371/journal.pone.0222465.g005
Table 2. Luminex assay using a human cytokine 30-plex panel on UBMC’s supernantant of Subject 1, following stimulation for 36 h with 37.5 ng/ml purified LPS
obtained from the indicated baterial species (E. coli, E. aerogenes, K. pneumoniae, P. mirabilis, A. calcoaceticus, C. freundii, P. aeruginosa). Abbreviation: SD, stan-
dard deviation.
P. mirabilis E. aerogenes A. calcoaceticus C. freundii P. aeruginosa E. coli K. pneumoniae
IL-6 pg/ml saturated signal saturated signal saturated signal saturated signal 1280 saturated signal saturated signal
SD - - - - 981 - -
TNF pg/ml 460 1320 117 105 8.37 2150 1780
SD 186 205 13 5 5 346 163
IL-1β pg/ml 1910 2440 945 938 47.2 2730 3060
SD 354 7 52 315 33 148 28
IL-10 pg/ml 246 345 132 97.1 0 389 318
SD 78 69 40 37 0 89 93
IL-12 (p40/p70) pg/ml 3210 3880 1610 1450 71.7 3880 3720
SD 1004 1457 191 481 39 813 1061
IFN-γ pg/ml 28.9 26 18.1 19.4 12.9 30.6 31.4
SD 5 2 0 1 1 6 8
IL-8 pg/ml 26600 24400 19600 25600 23200 22100 18300
SD 919 3041 5940 2616 1556 212 0
MIP-1α pg/ml 21600 26700 12900 15600 290 22200 18900
SD 1909 4525 2616 5586 133 2263 3606
MIP-1β pg/ml 38200 43600 18500 21600 383 48100 33100
SD 5798 4596 2616 9687 151 22345 6223
MCP-1 pg/ml 30000 28600 26600 29600 4080 29000 25800
SD 1414 283 1202 3041 2595 2051 2404
IL-1RA pg/ml 8050 10500 5350 5690 785 10800 10600
SD 1245 1464 78 1704 284 990 778
G-CSF pg/ml 4160 4820 2000 1860 0 5440 4620
SD 445 877 417 778 0 1110 566
IL-2R pg/ml 1290 1220 1170 1210 194 1340 1260
SD 7 57 14 35 0 106 35
(Continued)
Cytokine profiles of LPS-stimulated umbilical cord blood mononuclear cells (UBMC)
PLOS ONE | https://doi.org/10.1371/journal.pone.0222465 September 19, 2019 14 / 23
human fetal membranes in vitro and animal models of intrauterine infection. These com-
pounds have the potential to be safer and more effective than less selective inhibitors of inflam-
mation [90].
In conclusion, we showed that LPS of different vaginal gram-negative bacteria trigger dif-
ferent cytokine and chemokine responses and that individual UBMC differentially respond to
LPS stimulation. Further studies are needed to better understand the relationship between
intrauterine infection, inflammatory response and PTL, and to develop clinical approaches to
reduce preterm delivery and associated neonatal complications.
Table 2. (Continued)
P. mirabilis E. aerogenes A. calcoaceticus C. freundii P. aeruginosa E. coli K. pneumoniae
VEGF pg/ml 1100 1040 962 1030 343 1080 1030
SD 28 7 70 83 170 64 21
RANTES pg/ml 360 736 142 134 0 744 591
SD 204 361 37 65 0 336 216
GM-CSF pg/ml 261 350 133 120 21.1 333 254
SD 21 26 6 15 8 45 25
IL-7 pg/ml 240 243 225 237 108 239 225
SD 2 1 17 6 38 8 5
FGF-basic pg/ml 122 136 114 110 0 115 134
SD 11 22 2 0 0 0 0
IL-15 pg/ml 81.1 0 0 0 0 77.4 0
SD 7 0 0 0 0 0 0
MIG pg/ml 72.1 72.8 46 0 0 58.5 44.1
SD 4 6 0 0 0 1 3
HGF pg/ml 35.8 36.3 0 0 0 0 0
SD 0 0 0 0 0 0 0
IL-13 pg/ml 27.8 34.1 27.8 26.3 0 26.3 26.3
SD 0 0 0 2 0 2 2
IL-4 pg/ml 18.8 15.9 12.9 14.9 0 16.9 13.9
SD 0 1 0 6 0 6 4
IP-10 pg/ml 14.9 21 10.4 8.87 6.15 24.8 32.9
SD 6 3 1 1 2 8 16
IL-5 pg/ml 7.79 11 3.22 3.22 0 10.8 11.3
SD 2 0 1 1 0 3 3
Eotaxin pg/ml 4.43 4.49 4.02 4.08 0 4.26 4.14
SD 0 0 0 0 0 1 0
IL-2 pg/ml 4.97 5.49 0 4.72 0 5.23 4.97
SD 0 1 0 0 0 0 1
IL-17 pg/ml 0 0 0 0 0 0 0
SD 0 0 0 0 0 0 0
EGF pg/ml below detection below detection below detection below detection below detection below detection below detection
SD - - - - - - -
IFN-α pg/ml below detection below detection below detection below detection below detection below detection below detection
SD - - - - - - -
https://doi.org/10.1371/journal.pone.0222465.t002
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Fig 6. Levels of cytokines secreted by LPS-stimulated UBMC. Levels of pro-inflammatory (IL-6, IL-1ß, TNF) and
anti-inflammatory (IL-10) cytokines (A), of the TH1-polarizing cytokines IL-12 (p40/p70) and IFN-γ (B), and of the
chemokines IL-8, MIP-1α, MIP-1β and MCP-1 (C) released by LPS-stimulated UBMC. UBMC isolated from ten
uncomplicated deliveries of at-term newborns were stimulated for 36 h with 37.5 ng/ml purified LPS derived from the
indicated seven gram-negative bacteria (E. coli, E. aerogenes, K. pneumoniae, P. mirabilis, A. calcoaceticus, C. freundii,
P. aeruginosa). Unstimulated UBMC served as reference (Control). The TLR1/2 agonist PAM3 served as additional
control in seven out of ten donors. Cytokines levels in the respective UBMC supernatants were measured by Luminex.
Differences between unstimulated and stimulated conditions were evaluated using the non-parametric Mann-Whitney
U-test. Respective P values are indicated above each box plot. Medians (horizontal white line), arithmetic means
(horizontal black line) and interquartile ranges are shown. IL-6 levels in Subject 1 were above the detection range after
stimulation with six out of seven LPS variants (see also Figs 1–4 and Table 2), and thus the respective concentrations
were excluded from the graphic representation and statistical analysis.
https://doi.org/10.1371/journal.pone.0222465.g006
Fig 7. Summary of the cytokine profiles in UBMC stimulated with LPS of seven gram-negative bacteria. Median cytokine levels in LPS-stimulated UBMC isolated
from ten uncomplicated deliveries. Median cytokine levels are directly derived from the data presented in Fig 6. Due to log scale representation, values of 0 pg/ml were
replaced by 0.1; thus values depicted at 0.1 pg/ml along the x axis are actually equal to zero. IL-8, IL-6, MIP-1α, MIP-1β and MCP-1 showed the highest median level of
induction, followed by TNF, IL-1β, IL-10 and IL-12. IFN-γ showed the lowest median level of secretion.
https://doi.org/10.1371/journal.pone.0222465.g007
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